(function(doc, html, url) {
var widget = doc.createElement("div");
widget.innerHTML = html;
var script = doc.currentScript; // e = a.currentScript;
if (!script) {
var scripts = doc.scripts;
for (var i = 0; i < scripts.length; ++i) {
script = scripts[i];
if (script.src && script.src.indexOf(url) != -1) break;
}
}
script.parentElement.replaceChild(widget, script);
}(document, '
How similar is similar enough? The story of the β-blocker metoprolol
What is it about?
Metoprolol is a cardioselective β1-adrenergic blocking agent that shares part of its molecular skeleton with a large number of other β-blockers. Here we present its molecular and crystal structure as compared with that of the closely related betaxolol. Results show that crystal structure similarities do not imply similarities in macroscopic behavior: the two drugs respond differently to temperature stimulus.
Why is it important?
In this paper, the last of a series involving metoprolol & its commercial salts, we tried to rationalize the anisotropic thermal crystal expansion observed in the free base and in some of its salts. The impossibility to definitely find a reason for this behavior, not observed for example in the strictly related betaxolol compound, is a clear remind that although much has been done within the framework of structure–property/function relationships, much remains to be done, especially when APIs are concerned, due to the relevance of their solid-form properties in view of their pharmaceutical development.